Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
Top Cited Papers
- 1 March 2014
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 233 (1), 219-223
- https://doi.org/10.1016/j.atherosclerosis.2013.12.020
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The PCSK9 decadeJournal of Lipid Research, 2012
- Pathophysiology of Severe Familial HypercholesterolemiaJournal of Clinical Lipidology, 2012
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary ReportPEDIATRICS, 2011
- Drug Therapy of High-Risk Lipid Abnormalities in Children and AdolescentsCirculation, 2007
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemiaAtherosclerosis, 2004
- Global Burden of Cardiovascular DiseasesCirculation, 2001
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene MutationCirculation, 1995
- Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991